Of the 46 prioritized genes, six (FYN, DYRK1A, NOD2, CTSB, SV2C, ITPKB) were identified as promising drug targets for PD, each supported by at least eight PD-related publications in our literature review. Here, SV2C is linked to Parkinson disease.